Search Count: 15
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp4/5 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp5/6 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp6/7 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp7/8 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp8/9 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Sars-Cov-2 Main Protease (Mpro) C145A In Complex With Cleavage Site Nsp10/11 (P6-P1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-06-22 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 4/5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL, DMS
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 5/6
Organism: Severe acute respiratory syndrome coronavirus 2, Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2, Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL, DMS
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 7/8
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: EDO, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: EDO, GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 8/9
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 9/10
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 10/11
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 12/13
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 13/14
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
 |
Co-Crystal Structure Of Sars-Cov-2 Mpro C145A With Substrate Peptide 15/16
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2022-06-22 Classification: VIRAL PROTEIN Ligands: GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL